Get The App!
Loading the player...
Serum Tumor Markers in Management of Lung Cancer
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Dr. Edward S. Kim, MD, Levine Cancer Institute, discusses serum tumor markers in the management of lung cancer, filmed at IASLC 2015.
Lung Cancer Subtypes
Heterogeneity of Stage III NSCLC
What is the Role of Molecular Marker Testing in the Post-Operative Setting?
Managing 3 Compartments in Stage III NSCLC: Local Disease, Distant Disease, and the CNS
Serum Testing for Molecular Markers
What is Next Gen Sequencing?
Basics of Working up Lung Cancer
Pulmonary Function Tests: What are They, and What are They For?
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go